Advertisement

Topics

Top Players In Clear After US Court Confirms Abiraterone Patent Is Invalid

03:08 EDT 17 May 2019 | SCRIP

The sole US patent listed against Janssen’s Zytiga abiraterone prostate-cancer treatment is invalid, the US Court of Appeals has confirmed...

      

Related Stories

 

Original Article: Top Players In Clear After US Court Confirms Abiraterone Patent Is Invalid

NEXT ARTICLE

More From BioPortfolio on "Top Players In Clear After US Court Confirms Abiraterone Patent Is Invalid"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...